Programme

Overview: As radiotherapy outcomes continue to improve, there has been a significant increase in demand for re-irradiation for secondary or recurrent cancers. However, re-irradiation remains one of the most challenging areas of radiotherapy, as normal tissue risks arising from combined exposures must be carefully managed. This session will provide a review of clinical-decision making in re-irradiation, including consideration of key knowledge gaps and limitations in current clinical data. This will be followed by a discussion of the biological modelling of re-irradiation, including the calculation of combined equivalent doses in conventional and hypofractionated therapy, the use of time- and recovery-factors, and the potential role of systemic conditions beyond the irradiated organs on patient responses.

Overview: This session will examine how radiotherapy services can best balance efficiency, quality, and equitable access to care. Experts will debate the benefits and challenges of centralised and decentralised models, considering their impact on patient outcomes, access to treatment, workforce planning, and resource utilisation. Through real-world examples and discussion, participants will gain insights into strategies for delivering high-quality radiotherapy services across diverse healthcare settings.